A Phase II Study of Rituximab + ABVD for Patients With Hodgkin's Disease.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Rituximab (Primary) ; Bleomycin; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 07 Mar 2013 Primary endpoint added as reported by ClinicalTrials.gov.
- 04 Apr 2012 Actual patient number added 85 according to ClinicalTrials.gov.
- 04 Apr 2012 Actual end date (March 2012) added as reported by ClinicalTrials.gov.